The Prognostic Value of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma for Predicting Metastasis after Curative Resection

被引:10
|
作者
Minata, Mutsuko [1 ,5 ]
Harada, Kouji H. [2 ]
Kudo, Masatoshi [4 ]
Ikai, Iwao [3 ]
Nishida, Naoshi [1 ,4 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan
[2] Kyoto Univ, Sch Publ Hlth, Kyoto, Japan
[3] Kyoto Med Ctr, Natl Hosp Org, Dept Surg, Kyoto, Japan
[4] Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osakasayama, Osaka 5898511, Japan
[5] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA USA
关键词
Hepatocellular carcinoma; Vascular endothelial growth factor; E-cadherin; Recurrence; E-CADHERIN; RECURRENCE; EXPRESSION; OVEREXPRESSION; ABLATION;
D O I
10.1159/000345894
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Hepatocellular carcinoma (HCC) frequently recurs even after curative resection. The purpose of this study was to identify factors predictive for postoperative recurrence of HCC in patients who underwent curative resection using immunohistochemistry. Methods: Expression of vascular endothelial growth factor (VEGF), E-cadherin and cyclin D1 in HCC tissue were analyzed for 133 HCC patients who underwent curative resection of tumors using immunohistochemical analysis. Relationships of expressions and disease-free survival of HCC were evaluated using univariate and multivariate analyses. Results: The average period of follow-up of the patients was 6.7 years. Multivariate analyses revealed that only strong expression of VEGF in HCC tissue was significantly associated with metastatic recurrence (p < 0.001, hazard ratio, HR, 3.32). Conclusions: Evaluating VEGF in HCC tissue after surgical resection has predictive value for metastatic HCC recurrence. The ability to risk stratify should improve the treatment strategies after hepatectomy. Copyright (C) 2013 S. Karger AG, Basel
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [1] Expression of E-Cadherin and Vascular Endothelial Growth Factor in Noncancerous Liver Is Associated with Recurrence of Hepatocellular Carcinoma after Curative Resection
    Minata, Mutsuko
    Kudo, Masatoshi
    Harada, Kouji H.
    Ikai, Iwao
    Nishida, Naoshi
    ONCOLOGY, 2013, 84 : 88 - 92
  • [2] Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
    Umeda, Shinichi
    Kanda, Mitsuro
    Sugimoto, Hiroyuki
    Tanaka, Haruyoshi
    Hayashi, Masamichi
    Yamada, Suguru
    Fujii, Tsutomu
    Takami, Hideki
    Niwa, Yukiko
    Iwata, Naoki
    Tanaka, Chie
    Kobayashi, Daisuke
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    BMC CANCER, 2017, 17
  • [3] Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
    Shinichi Umeda
    Mitsuro Kanda
    Hiroyuki Sugimoto
    Haruyoshi Tanaka
    Masamichi Hayashi
    Suguru Yamada
    Tsutomu Fujii
    Hideki Takami
    Yukiko Niwa
    Naoki Iwata
    Chie Tanaka
    Daisuke Kobayashi
    Michitaka Fujiwara
    Yasuhiro Kodera
    BMC Cancer, 17
  • [4] Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection
    Deng, Biao
    Zhang, Xiao-Fei
    Zhu, Xu-Chao
    Huang, Hua
    Jia, Hu-Liang
    Ye, Qing-Hai
    Dong, Qiong-Zhu
    Qin, Lun-Xiu
    ONCOLOGY REPORTS, 2013, 30 (06) : 2795 - 2803
  • [5] Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma
    Ho, Ming-Chih
    Chen, Chiung-Nien
    Lee, Hsinyu
    Hsieh, Fon-Jou
    Shun, Chia-Tung
    Chang, Chi-Lun
    Lai, Yeun-Tyng
    Lee, Po-Huang
    CANCER LETTERS, 2007, 250 (02) : 237 - 249
  • [6] High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma
    Li, Tao
    Zhu, Yuhua
    Ren, Wanhua
    Xu, Shifeng
    Yang, Zhen
    Fang, Aiju
    Qin, Chengyong
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2750 - 2761
  • [7] High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection
    Hu, Jie
    Xu, Yang
    Shen, Zao-Zhuo
    Wang, Zheng
    Lu, Qing
    Yang, Guo-Huan
    Ding, Zheng-Bin
    Fan, Jia
    Zhou, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1359 - 1367
  • [8] Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
    Schoenleber, S. J.
    Kurtz, D. M.
    Talwalker, J. A.
    Roberts, L. R.
    Gores, G. J.
    BRITISH JOURNAL OF CANCER, 2009, 100 (09) : 1385 - 1392
  • [9] Metadherin Is a Prognostic Predictor of Hepatocellular Carcinoma after Curative Hepatectomy
    Ahn, Soomin
    Hyeon, Jiyeon
    Park, Cheol-Keun
    GUT AND LIVER, 2013, 7 (02) : 206 - 212
  • [10] Prognostic Value of Vascular Endothelial Growth Factor Levels in Patients With Hepatocellular Carcinoma Reply
    Kaseb, Ahmed O.
    Morris, Jeffrey S.
    Hassan, Manal M.
    Abbruzzese, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (09) : 1019 - 1020